Welcome to our dedicated page for BRASKEM SA SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRASKEM SA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRASKEM SA's regulatory disclosures and financial reporting.
BRASKEM SA filed an initial insider ownership report for director Chambriard Magda Maria de Regina. This Form 3 identifies her as a director of the company but does not list any share purchases, sales, or other insider transactions.
The filing shows no reported derivative positions or other equity-related holdings in this snapshot, serving mainly as a baseline disclosure of her status as a reporting person.
Braskem S.A. filed an amended Form 6-K outlining its 2026 corporate events calendar. The company plans to release its quarterly financial statements on May 13, 2026 (1st quarter), August 12, 2026 (2nd quarter), and November 11, 2026 (3rd quarter).
The calendar also sets the Annual Shareholders’ Meeting for April 29, 2026, with the management proposal and call notice scheduled for March 27, 2026. Braskem notes that public meetings with analysts are to be defined, with one date listed as November 12, 2026. The filing includes standard cautionary language on forward-looking statements, highlighting risks related to economic conditions, a geological event in Alagoas, related proceedings, and COVID-19.
Braskem SA director Correia Aires Edmundo Jose submitted an initial Form 3 ownership report for the company’s common equity. The filing identifies him as a director, not an officer or ten percent owner, and shows no reportable transactions or derivative positions in this initial statement.
BRASKEM SA disclosed that William Franca da Silva is a director by filing an initial Form 3, which is the first statement of insider ownership required for company insiders. The available data show no reportable buy, sell, or other share transactions associated with this filing.
BRASKEM SA executive Franco de Campos Raphael, who serves as Exec Officer & Head of Operation, filed an initial Form 3 statement of beneficial ownership. The filing reports no transactions, no derivative positions, and no reported holdings at this time.
BRASKEM SA director files initial ownership report with SEC
BRASKEM SA director Fernando Sabbi Melgarejo filed a Form 3, which is an initial statement of beneficial ownership for insiders. The filing does not list any share transactions or holdings, serving mainly to register his status as a reporting person.
BRASKEM SA director Helio Baptista Novaes filed an initial Form 3, identifying himself as a director of the company. The filing data shows no reported share holdings, no derivative positions, and no buy, sell, or other share transactions associated with this reporting person.
Braskem S.A. furnished a foreign issuer report summarizing the holdings and trading activity in its securities by management, controlling groups, fiscal council and technical or advisory bodies for April 2026 under Article 11 of CVM Instruction 358/2002.
The report presents opening and closing balances for common shares, class “A” preferred shares and American depositary receipts, such as an opening balance of 226,334,623 common shares and 79,182,498 class “A” preferred shares. Multiple sections state that no transactions in securities or derivatives were executed in April 2026 for the categories indicated.
The filing also reiterates Braskem’s usual caution on forward-looking statements, highlighting risks and uncertainties related to the geological event in Alagoas, associated legal proceedings and the impact of COVID‑19 on its business, financial condition and operating results.
Braskem S.A. submitted a Form 6-K as a foreign private issuer, mainly to report its securities and derivatives activity for April in line with Brazilian CVM Instruction # 358/2002 as amended by Instruction # 568/2015, including information on shares held in treasury.
The filing also includes an extensive disclaimer on forward-looking statements, highlighting that comments about strategy, future operations and the impact of the geological event in Alagoas and COVID-19 involve risks, uncertainties and assumptions, and refers readers to Braskem’s Form 20-F and subsequent Exchange Act reports for a fuller discussion of risk factors.
Braskem S.A. filed an amended Form 6-K outlining its 2026 corporate events calendar for investors. The company plans to release its quarterly ITR financial statements for 2026 on May 13, August 12 and November 11.
The calendar also sets the 2026 Annual Shareholders’ Meeting for April 29, with the management proposal and call notice dated March 27, and a public meeting with analysts on November 12. The filing includes a standard caution about forward-looking statements and related risk factors.